Abzena Expands GMP Cell-Based Potency Testing in US & UK
19 Nov 2024 //
PR NEWSWIRE
Abzena Expands Microbiology Lab for Biologic Manufacturing
30 Oct 2024 //
PR NEWSWIRE
Abzena, ProteoNix Expand Partnership
01 Oct 2024 //
CONTRACT PHARMA
AbZelectPRO Enables Faster Research Cell Bank Production
26 Sep 2024 //
PR NEWSWIRE
Abzena Supplies Clinical Trial Material For Angiex`s AGX101 Study
08 Aug 2024 //
PR NEWSWIRE
Abzena, Argonaut Partner to Provide a Fully Integrated Manufacturing Solution
21 Jun 2024 //
CONTRACT PHARMA
Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development
20 Jun 2024 //
PR NEWSWIRE
Abzena Launches LabZient™, an Analytical Platform
07 Feb 2024 //
PR NEWSWIRE
Abzena partners with FDA on publication demonstrating benefits of MAPPs assay
19 Dec 2023 //
PR NEWSWIRE
Abzena Names Thomas Castellano Chief Financial Officer
06 Jun 2023 //
CONTRACT PHARMA
Abzena Taps Sean O’Brien for Senior VP, Site Head at San Diego Facility
03 Apr 2023 //
PRESS RELEASE
Abzena Reinforces Senior Leadership Team
14 Mar 2023 //
CONTRACT PHARMA
In apparent transition, Abzena lays off 66 in San Diego
25 Jan 2023 //
FIERCE PHARMA
Pfizer inks deal to snatch Abzena`s new North Carolina manufacturing site
17 Jan 2023 //
PRESS RELEASE
Abzena Names Matthew Stober CEO
05 Jan 2023 //
CONTRACT PHARMA
Abzena Bulks up R&D Services to Include B Cell Discovery Tech
24 Sep 2022 //
PHARMACEUTICALCOMMERCE
Abzena Opens a New Biologics Testing Lab
11 Apr 2022 //
CONTRACTPHARMA
Abzena Opens a New Biologics Testing Lab
11 Apr 2022 //
CONTRACTPHARMA
Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement
03 Feb 2021 //
CONTRACTPHARMA
Abzena Expands ADC and Biologics Capabilities
15 Oct 2019 //
CONTRACT PHARMA
Abzena Completes ADC Tech Transfer
23 Jul 2019 //
CONTRACT PHARMA
Abzena, Lipum Sign Integrated CMC Agreement
19 Mar 2019 //
PRESS RELEASE